Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK interactions of AD-2111 and AD-2112 in Healthy Adults
NCT04375865Phase 1Completed
- Sponsor
- Addpharma, Inc.
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib and tramadol in pain (6 arms), sponsored by Addpharma, Inc. Primary endpoints: Area under the curve in time plot (AUCt) at 72 hours and Peak Plasma Concentration (Cmax) at 72 hours. Started May 2020; status: completed.
02
Drugs
celecoxibtramadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT04375865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375865.